Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-312025-03-31falsetrue2024-04-01No description of principal activity1010trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 01003350 2024-04-01 2025-03-31 01003350 2023-04-01 2024-03-31 01003350 2025-03-31 01003350 2024-03-31 01003350 c:CompanySecretary1 2024-04-01 2025-03-31 01003350 c:Director1 2024-04-01 2025-03-31 01003350 c:Director2 2024-04-01 2025-03-31 01003350 c:Director3 2024-04-01 2025-03-31 01003350 c:Director4 2024-04-01 2025-03-31 01003350 c:RegisteredOffice 2024-04-01 2025-03-31 01003350 c:Agent1 2024-04-01 2025-03-31 01003350 d:PlantMachinery 2024-04-01 2025-03-31 01003350 d:OfficeEquipment 2024-04-01 2025-03-31 01003350 d:OfficeEquipment 2025-03-31 01003350 d:OfficeEquipment 2024-03-31 01003350 d:OfficeEquipment d:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 01003350 d:CurrentFinancialInstruments 2025-03-31 01003350 d:CurrentFinancialInstruments 2024-03-31 01003350 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-31 01003350 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 01003350 d:ShareCapital 2025-03-31 01003350 d:ShareCapital 2024-03-31 01003350 d:RetainedEarningsAccumulatedLosses 2025-03-31 01003350 d:RetainedEarningsAccumulatedLosses 2024-03-31 01003350 c:FRS102 2024-04-01 2025-03-31 01003350 c:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 01003350 c:FullAccounts 2024-04-01 2025-03-31 01003350 c:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 01003350 6 2024-04-01 2025-03-31 01003350 e:PoundSterling 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure
Registered number: 01003350 (England and Wales)



 






HEARTACHES LIMITED


DIRECTORS' REPORT AND UNAUDITED FINANCIAL STATEMENTS


FOR THE YEAR ENDED 
31 MARCH 2025





Pages for Filing with Registrar


























 
HEARTACHES LIMITED
 

CONTENTS


Page
Company Information
 
1
Balance Sheet
 
2 - 3
Notes to the Financial Statements
 
4 - 9



 
HEARTACHES LIMITED
 
 
COMPANY INFORMATION

Directors
Sir Tim Rice 
Lady Jane Rice 
Donald Rice 
Eva Rice 




Company secretary
Eileen Heinink



Registered number
01003350



Registered office
40 Queen Anne Street

London

W1G 9EL




Accountants
Lewis Golden LLP

40 Queen Anne Street

London

W1G 9EL




Bankers
Coutts & Co
440 Strand

London

WC2R 0QS




Solicitors
Clintons
2 St. Giles Square

London

WC2H 8AP




1 -


 
Registered number: 01003350 (England and Wales)
HEARTACHES LIMITED


BALANCE SHEET
AS AT 31 MARCH 2025

2025
2024
Note
£
£

Fixed assets
  

Tangible fixed assets
 4 
158,944
61,745

Fixed asset investments
 5 
109,998
10,001

  
268,942
71,746

Current assets
  

Debtors
 6 
1,465,255
1,827,426

Current asset investments
 7 
12,260,968
10,780,839

Cash at bank and in hand
  
3,025,058
1,996,094

  
16,751,281
14,604,359

Creditors: amounts falling due within one year
 8 
(834,598)
(855,202)

Net current assets
  
 
 
15,916,683
 
 
13,749,157

  

Net assets
  
16,185,625
13,820,903


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
16,185,525
13,820,803

  
16,185,625
13,820,903


2 -


 
Registered number: 01003350 (England and Wales)
HEARTACHES LIMITED

    
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2025

The directors consider that the company is entitled to exemption from audit under section 477 of the Companies Act 2006 and the members have not required the company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the Directors' Report and the Profit and Loss Account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by:




Sir Tim Rice
Director

Date: 28 October 2025

The notes on pages 4 to 9 form part of these financial statements.

3 -


 
HEARTACHES LIMITED
 
 

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025 

1.


General information

Heartaches Limited is a private company limited by share capital, incorporated in England and Wales, registered number 01003350. The address of the registered office is 40 Queen Anne Street, London W1G 9EL.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A - small entities of Financial Reporting Standard 102, The 'Financial Reporting Standard applicable in the UK and the Republic of Ireland' ('FRS 102') and the Comapnies Act 2006.

  
2.2

Consolidation

The company and its subsidiary form a small group. The company is therefore not required to produce consolidated financial statements and has not done so. These financial statements present information about the company as a single entity.

 
2.3

Turnover

Turnover is recognised to the extent that it is probable that the economic benefits will flow to the company and the turnover can be reliably measured. Turnover represents royalties and other income received and is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
Turnover from royalties is recognised on the accruals basis in accordance with the substance of the relevant agreement. In some cases, whether or not a royalty will be received is contingent on the occurence of a future event. In such cases, turnover is recognised only when it is probable that the royalty will be received, which is normally when the event has occurred.

 
2.4

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Plant & machinery etc.
-
20-25% per annum on the reducing balance basis

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in the Profit and Loss Account.

4 -


 
HEARTACHES LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025 

2.Accounting policies (continued)

 
2.5

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

Investments in unlisted company shares and gilts, whose market value can be reliably determined, are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in the Profit and Loss Account for the year. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.

 
2.6

Debtors

Short-term debtors are measured at the transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.7

Cash and cash equivalents

Cash and cash equivalents are represented by cash in hand, deposits held at call with financial institutions, and other short-term highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

  
2.8

Financial instruments

The company has elected to apply provisions of Section 11 "Basic Financial Instruments" of FRS 102 to all of its financial instruments.

Financial instruments are recgnised in the company's Balance Sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

 
2.9

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

5 -


 
HEARTACHES LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025 

2.Accounting policies (continued)

 
2.10

Foreign currency translation

Functional and presentation currency

The company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in the Profit and Loss Account.

 
2.11

Pensions

Defined contribution pension plan

The company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payment obligations.

The contributions are recognised as an expense in the Profit and Loss Account when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the company in independently administered funds.

 
2.12

Taxation

Tax is recognised in the Profit and Loss Account.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the company operates and generates income.



3.


Employees

The average monthly number of employees, including directors, during the year was 10 (2024 - 10).

6 -


 
HEARTACHES LIMITED
 
 

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025 

4.


Tangible fixed assets





Plant and machinery etc.

£



Cost


At 1 April 2024
172,457


Additions
137,579


Disposals
(30,270)



At 31 March 2025

279,766



Depreciation


At 1 April 2024
110,712


Charge for the year
26,192


Disposals
(16,082)



At 31 March 2025

120,822



Net book value



At 31 March 2025
158,944



At 31 March 2024
61,745

7 -


 
HEARTACHES LIMITED
 
 

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025 

5.


Fixed asset investments





Shares in group undertakings and participating interests

£



Cost


At 1 April 2024
165,001


Additions
99,997


Disposals
(155,000)



At 31 March 2025

109,998



Impairment


At 1 April 2024
155,000


Impairment on disposals
(155,000)



At 31 March 2025

-



Net book value



At 31 March 2025
109,998



At 31 March 2024
10,001

8 -


 
HEARTACHES LIMITED
 
 

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025 

6.


Debtors

2025
2024
£
£


Trade debtors
156,429
477,005

Other debtors
1,308,826
1,350,421

1,465,255
1,827,426



7.


Current asset investments

2025
2024
£
£

Gilts
12,260,968
10,780,839



8.


Creditors: amounts falling due within one year

2025
2024
£
£

Corporation tax
364,513
360,147

Other taxation and social security
261,116
230,649

Other creditors
208,969
264,406

834,598
855,202





9.


Contingent liabilities

The company is part of a VAT group and thus a guarantee relationship exists within the group. The total contingent liability within the group is £107,955 (2024 - £134,297). Of this amount, the VAT liability of Heartaches Limited is £107,819 (2024 - £134,165).


10.


Related party transactions

At the balance sheet date, the amount owed to a director was £37,557 (2024 - £36,853 due from directors).

 
9 -